DAVID W RUSSELL
Osteopathic Medicine at 9 Ave, Seattle, WA
License number
Washington MD00030319
Category
Osteopathic Medicine
Type
Hematology
Address
Address
325 9Th Ave, Seattle, WA 98104
Phone
(206) 731-3241
Organization information
See more information about DAVID W RUSSELL at bizstanding.comDavid W Russell MD
PO Box 357720, Seattle, WA 98195
Categories:
Physicians & Surgeons
Phone:
(206) 598-4030 (Phone)
Professional information
Student At North Seattle Community College
Position:
Student at North Seattle Community College
Location:
Seattle, Washington
Industry:
Industrial Automation
Work:
North Seattle Community College
-
Student
USS Enterprise
- Norfolk, VA Jan 2008 - Feb 2012
-
Electrical Power Distribution Operator
Education:
Excelsior College 2009 - 2010
Associate of Science (AS), Engineering Naval Prototype Training Unit (Ballston Spa, NY) 2007 - 2008
Naval Nuclear Power Training Command 2006 - 2007
Western Piedmont Community College 2004 - 2005
Concurrent Enrollment
Associate of Science (AS), Engineering Naval Prototype Training Unit (Ballston Spa, NY) 2007 - 2008
Naval Nuclear Power Training Command 2006 - 2007
Western Piedmont Community College 2004 - 2005
Concurrent Enrollment
Skills:
Electrical Engineering, Security Clearance, Nuclear Energy, Microsoft Excel, Electricity, Preventive Maintenance, Electricians, Maintenance Management, Power Distribution, Electrical Safety, Power Generation, Electronics, Schematic, AC/DC, Nuclear, Calibration
Certifications:
Electrical Equipment Repair-person (643M), United States Military Apprenticeship Program
Low Voltage / Limited Energy Trainee [06], WA State Dept of Labor and Industries
Low Voltage / Limited Energy Trainee [06], WA State Dept of Labor and Industries
David J. Russell, Seattle WA - Lawyer
Office:
Keller Rohrback LLP
1201 3Rd Ave STE 3200, Seattle, WA 98101
1201 3Rd Ave STE 3200, Seattle, WA 98101
Specialties:
Commercial Litigation, Insurance Litigation, Personal Injury, Products Liability
ISLN:
901927772
Admitted:
1987, Washington, 1988, U.S. District Court for the Western District of Washington, 1988, U.S. Court of Appeals for the Ninth Circuit, 1998, U.S. District Court for the Eastern District of Washington, 2000, U.S. Supreme Court
University:
University of Washington, B.A., Political Science, 1983, University of Washington, B.A., French, 1984
Law School:
Columbia Law School, J.D., 1987
Links:
Site
Biography:
Professional Experience <br /><br />David Russell has been an attorney in Seattle since 1987 and has handled a wide variety of cases involving commercial litigation, banking litigation, contract dispu...
David William Russell, Seattle WA
Specialties:
Internal Medicine, Hematology, Cardiovascular Disease, Hematology & Oncology, Hematology
Work:
Harborview Medical Center Hematology Oncology Clinic
325 9Th Ave, Seattle, WA 98104
325 9Th Ave, Seattle, WA 98104
Education:
Cornell University (1989)
Attorney At Keller Rohrback
Position:
Attorney at Keller Rohrback
Location:
Greater Seattle Area
Industry:
Law Practice
Work:
Keller Rohrback
-
Attorney
Independent Arts And Crafts Professional
Location:
Greater Seattle Area
Industry:
Arts and Crafts
Owner At David Russell Design
Position:
owner at David Russell Design
Location:
Greater Seattle Area
Industry:
Graphic Design
Work:
David Russell Design
-
owner
Adeno-Associated Virus (Aav) Isolates And Aav Vectors Derived Therefrom
US Patent:
6156303, Dec 5, 2000
Filed:
Jun 11, 1997
Appl. No.:
8/873168
Inventors:
David W. Russell - Seattle WA
Elizabeth A. Rutledge - Seattle WA
Elizabeth A. Rutledge - Seattle WA
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 4800, C12N 15864, C12N 1564, C12N 510
US Classification:
424 932
Abstract:
The present invention provides isolated adenovirus-associated viruses ("AAV"), including AAV isolates designated AAV3B and AAV6. The invention also provides nucleic acid molecules of AAV3B (SEQ ID NO: 1) or AAV6 (SEQ ID NO: 2), including DNA or RNA, and provides substantially purified polypeptides encoded by AAV3B or AAV6, as well as antibodies specific for such polypeptides. The invention also provides infectious AAV3B and AAV6 clones; AAV viral vectors, which can be hybrid AAV viral vectors; AAV vector plasmids; and AAV helper plasmids; each comprising at least a portion of an AAV3B (SEQ ID NO: 1) or AAV6 (SEQ ID NO: 2) nucleic acid molecule. The invention further provides host cells containing at least a portion of an AAV3B or AAV6 nucleic acid molecule and progeny cells derived therefrom, and provides non-human transgenic mammals having an AAV vector genome stably integrated in a chromosome. The invention also provides methods of producing a polypeptide or an RNA by expressing the polypeptide or the RNA from an AAV viral vector in a cell, and methods of treating a pathologic condition in a mammal, comprising transducing cells of the mammal with an AAV viral vector containing a heterologous nucleic acid sequence. The invention also provides AAV3B or AAV6 nucleotide sequences, which can be useful, for example, as probes for identifying the presence of AAV3B or AAV6 nucleic acids in a sample.
Method For Increasing Transduction Of Cells By Adeno-Associated Virus Vectors
US Patent:
5834182, Nov 10, 1998
Filed:
Feb 25, 1997
Appl. No.:
8/750274
Inventors:
Ian E. Alexander - Middle Dural, AU
David W. Russell - Seattle WA
A. Dusty Miller - Seattle WA
David W. Russell - Seattle WA
A. Dusty Miller - Seattle WA
Assignee:
Fred Hutchinson Cancer Research Center
International Classification:
C12N 1587, C12N 500, C12N 1586, C12Q 170
US Classification:
435 5
Abstract:
This invention includes methods for increasing the efficiency of transduction of cells, including non-dividing cells, by recombinant AAV vectors. The methods utilize agents that alter certain aspects of DNA metabolism, more specifically, that affect DNA synthesis and/or affect repair, that impact on maintenance of chromosomal integrity, and/or that cause damage to the cellular DNA. Agents and vectors can now also be preselected and screened for transducing ability and/or transducing agents for their effect on DNA metabolism. These agents include tritiated nucleotides such as thymidine, gamma irradiation, UV irradiation, cis-platinum, etoposide, hydroxyurea and aphidicolin.
Parvoviral Production Of Hla Homozygous Cells
US Patent:
8105831, Jan 31, 2012
Filed:
Mar 7, 2008
Appl. No.:
12/044471
Inventors:
David W. Russell - Seattle WA, US
Roli K. Hirata - Seattle WA, US
Roli K. Hirata - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C12N 15/86, C12N 15/87, C12N 5/02
US Classification:
435375, 435455, 435456, 435463, 4353201
Abstract:
The present invention provides methods of generating a mammalian cell that is homozygous at a locus of interest, as well as cells made by the method. The present invention further provides methods of using the cells.
Hla Homozygous Cells
US Patent:
8586358, Nov 19, 2013
Filed:
Dec 21, 2011
Appl. No.:
13/333010
Inventors:
David W. Russell - Seattle WA, US
Roli K. Hirata - Seattle WA, US
Roli K. Hirata - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C12N 5/00, C12N 15/00
US Classification:
435366, 435455, 435456
Abstract:
The present invention provides methods of generating a mammalian cell that is homozygous at a locus of interest, as well as cells made by the method. The present invention further provides methods of using the cells.